Guest Editor’s Note: Special Series on Medical Communications Charles C. Depew EditorialNotes 31 December 2000 Pages: 991 - 993
The Core Curriculum for Medical Communications Professionals Practicing in the Pharmaceutical Industry David A. GravesRobert P. Baker OriginalPaper 31 December 2000 Pages: 995 - 1008
Pharmaceutical Industry Medical Communications Departments: Regulatory and Legal Perils and Pitfalls Fred J. SalterPaul F. KramerNancy L. Palmer-Shevlin OriginalPaper 31 December 2000 Pages: 1009 - 1015
Medical-Legal Considerations Regarding the Provision of Medication-Related Information to Consumers by a Pharmaceutical Manufacturer Sandy Kline OriginalPaper 31 December 2000 Pages: 1017 - 1020
Preparing for a Product Launch in a Medical Communications Department Amy L. WernerKim M. Murray OriginalPaper 31 December 2000 Pages: 1021 - 1033
Developing an Automated Telephone Triage System for a New Product Launch Linda F. Gundaker OriginalPaper 31 December 2000 Pages: 1035 - 1039
Strategies for Increasing Drug Inquiry Response Efficiency Charles F. Curran OriginalPaper 31 December 2000 Pages: 1041 - 1047
History and Evolution of Field-Based Medical Programs Donna K. MorganDavid E. DomannRobert J. Moss OriginalPaper 31 December 2000 Pages: 1049 - 1052
Expanding Medical Communications Services to Internal Customers Amy L. WernerTimothy E. PoeJames A. Graham OriginalPaper 31 December 2000 Pages: 1053 - 1061
Establishing a Medical Knowledge Extranet to Enhance Medical Communications Kirk HoffmanPat PallanschSteve Shafer OriginalPaper 31 December 2000 Pages: 1063 - 1068
The Applied Therapeutics Team: An Innovative Model of Drug Information in the Pharmaceutical Industry Susan E. MalechaSandra A. WiejowskiRobert J. Holt OriginalPaper 31 December 2000 Pages: 1069 - 1075
Establishing Global Medical Information Services: Practices and Pitfalls Jennifer L. Riggins OriginalPaper 31 December 2000 Pages: 1077 - 1080
Pharmaceutical Industry-Based Medical Information in Canada Lawrence HoughLynn Campbell OriginalPaper 31 December 2000 Pages: 1081 - 1087
Industry-Based Medical Information in Europe: Practices and Customer Expectations Andrew S. RobsonDavid Robson OriginalPaper 31 December 2000 Pages: 1089 - 1095
Industry-Based Medical Information in Japan: Practices and Customer Expectations Noriko TaniuchiIsha I. Bhattacharyya OriginalPaper 31 December 2000 Pages: 1097 - 1103
Outsourcing Industry Medical Information Services Neelima FirthLarry J. DavisDavid A. Graves OriginalPaper 31 December 2000 Pages: 1105 - 1113
A Combined Industry and Academia Residency Program Gary M. McCartBarry J. GrobmanDavid A. Graves OriginalPaper 31 December 2000 Pages: 1115 - 1119
Drug Information in Industry Versus Academia: A Pharmacy Resident’s Perspective of a Sample Case Angie S. GrahamDavid A. GravesCandy Tsourounis OriginalPaper 31 December 2000 Pages: 1121 - 1127
Medical Center Clinical Rotation for Pharmaceutical Drug Information Professionals Martin L. PollockAnthony Fazio OriginalPaper 31 December 2000 Pages: 1129 - 1132
Evaluation and Critical Appraisal of a Random Sample of Drug Information Practice In United States Academic and Industry Medical Information Centers Meghan E. ShannonSusan E. MalechaMary Lynn Moody OriginalPaper 31 December 2000 Pages: 1133 - 1138
An Industry-Wide Evaluation of Drug Information Services Rebecca I. DoyleKaren H. SongRobert P. Baker OriginalPaper 31 December 2000 Pages: 1139 - 1148
Hosting an Open House for a Medical Information Department: An Effective Educational Method Patricia A. MatthewsPolly N. JacobsCarol B. Rockett OriginalPaper 31 December 2000 Pages: 1149 - 1154
An Interdepartmental Survey of Medical Information Services: Evaluating the Impact of an Open House Kévin S. ByrneJulie I. PapayMichael H. Ames OriginalPaper 31 December 2000 Pages: 1155 - 1162
Merger Mania: Impact on the Medical Information Department Colleen M. CulleyKirk H. HoffmanRomana Slavik OriginalPaper 31 December 2000 Pages: 1163 - 1168
New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms Joseph A. DiMasi OriginalPaper 31 December 2000 Pages: 1169 - 1194
Use of Generic Drugs and Effects of the Reference Price System in Sweden J. Lars G. NilssonArne Melander OriginalPaper 31 December 2000 Pages: 1195 - 1200
Pricing and Reimbursement of Pharmaceutical Products in France Beatrix Friedeberg-Steward OriginalPaper 31 December 2000 Pages: 1201 - 1205
The Role of the Food and Drug Administration in Pharmacoeconomic Evaluation During the Drug Development Process Jennifer KimCarolyn Blank MorrisKevin Alan Schulman OriginalPaper 31 December 2000 Pages: 1207 - 1213
Comparative Course and Outcome of the Mutual Recognition Procedure with Two Related Progestagen-Only Contraceptive Products: Cerazette® and Implanon® Willem de BoerWim B. J. Mens OriginalPaper 31 December 2000 Pages: 1215 - 1221
Pharmacist Employment and Satisfaction Trends at Eli Lilly and Company Jennifer L. RigginsBrandi H. Plowman OriginalPaper 31 December 2000 Pages: 1223 - 1229
Approval Standards for Alfa Interferon Subtypes Paul P. TrottaGuido AntonelliPeter von Wussow OriginalPaper 31 December 2000 Pages: 1231 - 1246
Preventing Adverse Drug Events (ADEs): The Role of Computer Information Systems Qing YanC. Anthony Hunt OriginalPaper 31 December 2000 Pages: 1247 - 1260
Some Commentary on Maximizing the Statistician’s Value to the Pharmaceutical Industry Rafe M. J. Donahue OriginalPaper 31 December 2000 Pages: 1261 - 1264
Statistical Approaches to Accepting Foreign Clinical Data Norisuke KawaiMasakazu AndohMasashi Goto OriginalPaper 31 December 2000 Pages: 1265 - 1272
The Development of Standard Economic Datasets for use in the Economic Evaluation of Medicines Martin E. BackhouseAri GnanasakthyHenry Glick OriginalPaper 31 December 2000 Pages: 1273 - 1291
Insourcing International Clinical Trials to Affiliates: A Business-Driven and Medically Sound Strategy Philip ChaikinSylvain DurrlemanMartin Ford OriginalPaper 31 December 2000 Pages: 1293 - 1301
Clinical Study Preparation: Sponsor Support for the Quality of Site Management C. I. CordaroG. Tabusso OriginalPaper 31 December 2000 Pages: 1303 - 1308
The Informed Consent Form: Document Development and Evaluation Mark Hochhauser OriginalPaper 31 December 2000 Pages: 1309 - 1317
From “Too Much, Too Late” to “Right First Time”: Quality Guru Deming’s Advice for Clinical Trials Mats H. Lörstad OriginalPaper 31 December 2000 Pages: 1319 - 1328
Reading Level of Drug Information Printouts: A Barrier to Effective Communication of Patient Medication Information Philip D. Rolland OriginalPaper 31 December 2000 Pages: 1329 - 1338
Herbal Supplement Information and the Consumer Alicia S. BouldinMickey C. SmithEdward M. Croom JR. OriginalPaper 31 December 2000 Pages: 1339 - 1353
A Progress Report: Drug Information from 1970 to 2000 Charles F. Curran OriginalPaper 31 December 2000 Pages: 1355 - 1363
Cost-Effective Realization of an International Product Information Database Tilo Netzer OriginalPaper 31 December 2000 Pages: 1365 - 1372
